360° Coverage : Galapagos tests new antibiotics for resistant bacteria

10 Updates
  TV Balla Trending News

Galapagos tests new antibiotics for resistant bacteria

Source: CNBC, Nov 26 2012, 4:52am CST

BRUSSELS (Reuters) - Belgian biotechnology group Galapagos is testing a new class of antibiotics that could be used to combat bacteria that have become resistant to other forms of medication. The group said on Monday that in la ...

Continue reading on: CNBC

 
 
Update
10

3 days ago

Galapagos creates new warrant plan

Source: MarketWire  |   May 17 2013, 11:11am CDT

MECHELEN, BELGIUM--(Marketwired - May 17, 2013) - Galapagos NV (EURONEXT BRUSSELS: GLPG) announced today that its Board of Directors created 648,490 warrants under a new warrant plan for the benefit of employees, direc ...

Continue reading on: MarketWire  More like this

 
Update
9

3 days ago

Belgium's Galapagos says on track to meet 2013 guidance

Source: Reuters  |   May 17 2013, 12:43am CDT

BRUSSELS May 17 (Reuters) - Galapagos, the Belgian developer of drugs to fight autoimmune diseases such as lupus and rheumatoid arthritis, said it was on track to meet its full-year revenue guidance this year. The company, whi ...

Continue reading on: Reuters  More like this

 

Who is this Celebrity?

                                    .+##############++#++########+++;'+#++#'''#'+;'+'#####;.               
                                  `.+#######@@#######+###########+#+###+'+'#''+:+'++'+#####'.`             
                                 ``+#########@#####+'+##################'++'+':;###+#+++####'`             
                                 `'#######@@####################@@##@#####'++#+########+######`            
                               ``.'#####@###@@@###############@@#@@@##@########################`           
                              ...`####@######@#########@###@@@@@@@##@##@#@#@#############+####+'`          
                               +:,##@@@##@#@@@#############@@@@@@@@@@@##@@@@@##@+#@#############,          
                               ,######@@@##@####@#####@#@#@@@@@@@@@@@@#@@@@@###@@@@########@####+          
                               `+####@@#@@@@#@@######@#@#@@@@@@@@@@@@@@@@@@@@@@@@@@@@@###++######,         
                                '###@@@#@@#@###########@#@@@@@@@@@@@@@@@@@@@@@@@@@@@@#@###+#######`        
                               :####@#@#@@@#############@@@@@@@@#@@@@#@@@@@@@@@@@@@@@#@####+######,        
                              `:####@#@@@@@############@@@@@@@@@@@@#@@@@@@@@@@@@@@@@@##@##+'+#####+`       
                              `+#####@#@@@##############@@@#@@@@@@@@@@@@@@@@@@@@@@@@@##@####+'#####`       
                              '####@##@@@###############@@@#@@@@@@@@@@@@@#@@@@@@@@@@@##@###++++####;       
                             `###@@#@@@#@################@@@@#@@@@@@@@@@@@@@@@@@@@#@@@######+++#####`      
                            `'##@@@@###################@@@@@#@@@@#@@@#@@@@@@@@@@@@@@@@#@#####++#####,`     
                           `.+#@#@@@@#@##@##############@@#@@#@@@@@@@@@@#@@@@@@@@@#@@@######+++#####'.`````
                           `+###@@@@@@@@##################@#@@@@#@@@@@@##@@@@@@@@@#@@@#@#####+'++####'::,,,
                          `,#####@#@@@@#@##+###############@#@@@@@@@@@@#@@@@@@@@#@#@@@######++++######@####
                         ``:#####@@@@@@@#++###############@@#@##@@##@@#@#@@@#@@@@@#@@@@#####+++++#####@@###
                        ``.####@#@@@@@@####+###+###############@#@@#####@@@@@@#@@@@#@@@#####++#+''+####@###
                        ``:###@@@@@@@@#@#+#+#++#######################@#@#@@@@#@@@@#@@@########+++#########
                       `  :##@@@@@@@@@@#+#####+#######+#############@##@@@@@@@@@#####@#######+#+++#####@###
                        ``###@@@@@@@@#@#+'##+#+##+##+##################@@@@@##@####@#@#@#####+#+++####@#@##
                         `##@@@@@@@@@@@+##+#+####+#++####################@####@##############+#+'++#####@##
                         .##@@@@@@@@@##++#++####+#++'+######################@#@##############++#+++#####@@#
                        `:#@@@@@@@@@#@##+#++##+++';++##+#+###########################@#####+####+++#####@@@
                         ,##@@@@@#@@@#+#+####'+##++'+++#####################################+##++#+####@@##
                         :#@@@@###@@###+#++'#++#+###+#++'++#################################+##+'+++####@@#
                         .##@@@#######+#+++++#######''#'#+++##++##+#######+################+'+#+++++####@##
                      `,,.##@@@@#########+#+###########+++++#++##++#####+'#+###############''+#'++#'#######
                     :;::::#@@@@@######+#+##############+#++#++++'+##+#++:#+####+##########+++#+++++#####@#
                    .;;::::'#@@@@######################+++##+'##'+'+++++:'#+####++#########+'+##++#########
                    ,::;;:,;#@@@@########++#############+##++##'+++++''::+++####+++####++##+'+##++#+#####@@
                   `:::;;;::#@@@###+###############@####+#+###+'##+''+:,:'+++#++#++##+#++##++;##++#++#####@
                   ::,:;::;:+#@@###+###########@###+#########':+###+',,,'+'''+#++++##+####+#+'###+#'######@
                   ::,::,:,;'######+++#######@######'+###+#';:'####+:.,;+++#++'''++###+#+#++'+###+#'#####@#
                   ,::;,,,,;''####++++##############'+#+++;,,,+###++:,,:++##+'''+#'+#+#++###++###+++#####@#
                   ,,::,..,;'++##++'+++##''########++#+++:,,.,###+',,,:'++####'++++##+'+'#+##+####+#####@##
                   ,,:,..,:'''++++';';;+';'+++'';;:'++++';::,+###;,.,::+#####+''##+###'+'++#######+++##@#@#
                   ,,:,...,,'+'++'';;;'';;'';;:::,,,:'++++'''###'+,,,::#+####++++####+++'#+##+#####++######
                  `,;,,,,:::;+'+'';;;;;;;;;;:::::,,,::::''++###';,,,,,'+###+#+++#####+#++#+##+##########@##
                  .,,.,,,:,:;'''';;;;;;;;;;::::::;:::;;:;;;'###';:,,,,;++###:'''######'##++########+####@@@
                  ,:,,,,,,,,:'''';;;;;;;;;::::::''''+++';;;;#+;+;:,,,,;#+##+'++########+#++##@######+#@##@@
                  ::.,,,,.,:;;;';;;;;:;;:::::::'+######+''';;;:::::,,,''+#';+;;#######+#+++##@#+######@@##@
                  ::,,,,..,::;;;;;;;::::::::;:;+#####+##';;';;;::,,,,;;:++;;';;'####++##+'+##@#######@##@#@
                  ::,,,,..,,:;;;;;::::::::::;:;+#'#+#++.:+''';::::,,,,,,+';;;:'####+#+##+''###########@@@##
                  ,,,,:,.,,,:;;;;:::::::::::::;;''+#++:.,,#'';::::,,,,,,':::;''####+++##';'##########@#@@##
                  .,:,,,.,,,:;;;;;::::::::,,,,;;;;;;;'+;:::#'':,:::,..,,:::::;++########+''##########@@@@@@
                   ,,:,,,,,,;;;;;;;:::::::,,,,::;:::::;;;'+++::,:::,,.,,::::;''+'+#+#####+#######+###@@@@@#
                   ,,:,,,,,,;;;;;;:::;:::,,,,,,:::::,,::;;;;;':,,::,..,,::;';;;''+;;;+###+############@@@@#
                   :,:,,,;,,;;;;;;;:;::::,,,,,,,,,::::::;;;;:,,,,::,..,,:;':;+##++';''+;;;############@#@@@
                   ,,,:,,:,,;;;;;;;;;:::,,,,,,,,,,,::::::::::,,:,::,,.,,:';+######++'';;:;+###########@@@@#
                    :,,,,,::;;;;;;;;;:::,,,,,,,,,,,,,,,,,,,,:,:,::,,,,,,;:+'++++#'###+';:;+###########@@#@@
                    :,,,,,::;;;;;;;;;:::,,,,,,,,,,,,,,,,,,,,,,:,,:,,,,,:':++#+++#,,###'';;+############@@@#
                   `:,;,,,,:;;;;;;;;;:::,,,,,,,,,,,,,,,,,,,,,,:,,,,,,,,:'::;;;'#',,;###+;'#############@@@#
                   :,:,:,,,,;;;;;;;;;::::,,,,,,,,,,,,,,,,,,,,,,,,,,,,,::;;,,::;;'+#####+;+#############@@@#
                  `'.,:,.:,,;;;;;;;;;:::::,,,,,,,,,,,,,,,,,,,,,,,,,,,:::;;:,:,::;;''+##''+++######@###@@@@#
                  ,;.,,;,,,,;;;;;;;;;:::::,,,,,,,..,,,,,,,,,,,,,,,,,,,::;;:,::::::;;;++''++###@#@#@###@@@##
                 `,,,+,:.:::;;;;;;;;;::::,,,,,,,......,,,,,,,,,:,,,,,,::;;::,::::::;';;;'++####@@@@@@#@@@@#
                 ,,.,###+##+;;;;;;;;:::::,,,,,,......,,,,,,,,,:::::,,,::;;:::::::::::::;;++##@@@@@@@@#@@@@#
                 ::,,######';;;;;;;;:::::,,,,,,....,.,,,,,,,::::::,,,,::;::::::,,:::::::;#####@@@@@@@#@@@##
                `;,`###++##';;;;;;;;::::::,,,,.....,,,,,,,,::::::::,,,::;::,,,,:,:::::::;###@#@@@@@@@#@@@##
                ,,::###;###';';;;;;:::::::,,,,,,,,,,:,,::,,::::::::,,,:;:,:,,,,,,:,::::;;###@#@@@@@@@#@@@##
               `;..#+##+###';';;;;;:::::::,,,,,,,,,,::::,,::::::::,,,,:;::,,,,,,,,:::::;;##@@#@@@@@@@#@@@##
               `,.##+#,####';';;;;;::::::::,,,,,,,:::::,.::,,,,::,,..,:;:,,,,,,,,::::::;'##@@@@@@@@@@#@@@##
              `,,.#;++,###+';;;;;;;::::::::::,::::::,,...,::,,,::,,..,,;:,..,,,,,::::::;+##@##@@@@@@@#@@###
             ``,,#;,#:'###+';';;;;:::::::::::::;;:,,...,,,:::;::::,,,,:;:,,,,,,,,:::::;;###@@#@@@@@@@@@@###
             `.,+#;++,+###+;;;;;;;::::::::::::::,,,,,,,,,,,:;::;:::,,,;;:,,,,,,,,:::::;;###@#@@@@@@@@@@###+
              .,#:'+:'####+';;;;;;:::,:::::::::::,,,,,,,,,,,,:,:;;:::;;:::,,,,,,,::::;;'##@@#@@@@@##@######
              ,#';+#::'##+';;;;;;;::::,:::::,::::,,,,,,,,,,,,,,,:;;;''';:,,,,,,,,,:::;;##@@@@@@@@##########
             .'#.',:'++##'';;;;;;::::,,::,::,,:::::,,,,,,,,,,,,::::;;;:::,:,,,,,,:::;;'###@@@@@@###########
             ,''':+;,+####';;;;;:::::,,::,,:,,,:';;:::,,,,,,,,,,,,:;;:::,,:,,,,,,:::;'###@@#@@@@###########
            `'#:;:;,.+####''';;;:::::,,::,,,,,,,,'+';;::,,,,,,,,,,,::::::,,:,,,,,::;;;###@@#@@@############
           ``;#',',,;####+';';;;:::::,,,:,,,,,,,,:;;';;;;:::,,,,,,,::::::::::,,::::;'####@@@@@@############
          ` +,#::'.`+####+';';;;:::::,,,:,,,,,,,,,:;;'';;;::::,,,,,:::::::::::::::;;'######@@@@############
            :+..;,..+###'+';;;;;;::::,,,::,,,,,,,,:;;;;;';;;;;;;:::::::::::::::::;;'#####@@#@@#############
           ;:+,,+,`,+###''';';;;;::::,,,::,,,,,,,,,:;;:;;;:';;;;;;;;;::;::::::::;;''@####@@@#@#############
           ',,,;,``'####+'';;';;;::::,,,,,,,,,,,,,,,;;;;::::;;''';;'';';;::::::;;''####@#@@@@@#############
          .,',;:.`,+###'+'';;';;;:::::,,,:,,,,,:,,,,:;;;;,,,::;;'+++'+'';;::::;;'''####@#@@@@@#############
          +,:',.`.:+#+#'+'';;'';;;:::,,,,,,,,,,:,,,,,,;;;;.::::;;;';;'':,,,:::;;''@####@#@@@@##############
         `:',',.`.'###'#+'';;;';;;::::,,,,:,,,,:,,,,,,,:;:;;;;;;;;;;;':::::::;;;''@###+@#@@@@#######+######
          #,,',`.,+#+#;#'';;;;'';;;:::,,,,:,,,,,,,,,,,,,,:;;:;;;;;';';:::::::;;;'@@###+##@@@@######++######
         `',:,```;+##+'+'';;;;;;;;;::::,,,:,:,,,::,,,,,,,,,::;;;;;;;;;::::::;;;;'###@####@@@@#######+######
         `:,#.``.'+##'+''';;:::;;;;;:::,,,,:,,,,,:,,,,,,,,,,,::::::::::;:::;;;;'@###@####@@@###############
         `,.+.``,+++#:''';;;:::::;;;;:::,,,,:,,,,,,,,,..,,,,,,,:::::::;;:::;;;;'@###@####@@@@##############
          .`;``.+'##''''';;;:::::::;;;:::::,:,,,,,,,,,.,.,,,,,,,::::::;:::;;;;'@@###@##@#@@@@##############
          :.;``.++##;''';;;;::::::::;;;::::::,,,,,,,,,....,,,,,,:::::;:;::;;;'#@####@####@@@###############
          :.:``,'+++'''';;;:::::::::::;;:::::::,,,,,,....,,,,,,::::::;;;:;;;''@#####@####@#################
          ':'``+;##'''';;;;::::::::,:::;;;::::::,,,,,.....,,,,,:::::;;;;;;;;'@@###++@##@#@#################
          +.,`.;+++';;;;;;:::::::,,,,:::;;;:::::,,,,,...,,,,,,,::::;;;;;;;''@@#####+@##@#@#################
          :,;.;;++';;;;;;;:::::::,,,,,::::;;;:::,,,,,,,,,,,,,,,:::;;;;;;;''@@######+@##@###################
          `;;.+;'';;;;;;;:::::::,,,,,,,,,::;;;:::,,,,,,,,,,,,,,:::;;';;''#@@#######+@##@###################
           +'.;';;;;;;;;;:::::::,,,,,,,,,,:::;;::::,,,,,,,,,,,:::;;''';'@@@########+#######################
           `#;';;;;;;;;;::::::::,,,,,,,,,,,,::;;:::,,,,,,,,,,,:::;''''#@@@#########+#######################
            ##';;;;:::;;:::::,,,,,,,,,,,,,,,,,,:';:::,:::,:::::;;''+#@@@###########+@######################
           ;+#';:;;::::::::::,,,,,,,,,,,,,,,,,,::;';;:::::::::;;'+@@@@#############+@#+@###################
       `:,'';##;:::::::::::::,,,,,,,,,,,,,,,,,,,,::;++'';;;;;;'#@@@@@#############++@#+@###################
     `:':,;:';#';::::::::::::,,,,,,,,,,,,,,,,,,,,:::::;'#####@@@@@@###############++###@@##################
    ';,::,.;'''#;;::::::::::,,,,,,,,,,,,,,,:,,,,::::::;;'+##@@@@@@################++###################+###

Click ASCII Image to Reveal Celebrity

 
Update
8

25 weeks ago


Quote:
"We expect in the coming weeks substantial news flow from Galapagos which should convince investors that the company is more than just GLPG634"


Source: CNBC

 

Latest TV Show News

 

Currently Trending

 
Update
7

4 days ago

ThromboGenics says U.S. sales of Jetrea top $10 million

Source: Reuters  |   May 16 2013, 10:52am CDT

BRUSSELS May 16 (Reuters) - Belgian drug developer ThromboGenics said on Thursday U.S. sales of its eye drug Jetrea have exceeded $10 million, after the drug was launched there at the start of the year. ThromboGenics, ...

Continue reading on: Reuters  More like this

 
Update
6

4 days ago

Lakewood-Amedex Announces Results Demonstrating The More Rapid Direct Bactericidal Activity Of Novel Bisphosphocin Class Of Antimicrobials

Source: Freshnews.com  |   May 16 2013, 10:09am CDT

SARASOTA, Fla., May 16, 2013 /PRNewswire/ -- Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that a recent series of in vitro studies have provided new evidence that its novel class of antimicro ...

Continue reading on: Freshnews.com  More like this

 

Recommended

 
Update
5

4 days ago

Concurrent Septic Arthritis and Osteomyelitis in Children

Source: Journal of Pediatric Orthopaedics  |   May 15 2013, 6:32pm CDT

You could be reading the full-text of this article now... Introduction: Septic arthritis and osteomyelitis can both independently cause substantial morbidity. With concomitant septic arthritis and osteomyelitis, the septic arthritis may be treated withou ...

Continue reading on: Journal of Pediatric Orthopaedics  More like this

 
Update
4

5 days ago

2 BioPharma Catalyst Trades And 1 Strong Acquisition Target Rumored To Be In Play

Source: Seeking Alpha  |   May 15 2013, 8:12am CDT

Today, we look at two companies with significant short-term catalysts quickly approaching, and one company that could be acquired before the year is over. Catalyst trades can be very lucrative, with several ways to trade them. For examp ...

Continue reading on: Seeking Alpha  More like this

 
Update
3

6 days ago

Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Propel Insmed

Source: Seeking Alpha  |   May 14 2013, 9:36am CDT

The Orphan Drug Act was passed in January 1983 to encourage companies to develop drugs that treat rare medical conditions. Companies that receive Orphan Drug Status gain certain financial incentives such as a longer period of ex ...

Continue reading on: Seeking Alpha  More like this

 
Update
2

6 days ago

Antibiotics for Back Pain

Source: Big Think  |   May 13 2013, 11:59pm CDT

It sounds preposterous: antibiotics for back pain? What on earth could antibiotics possibly do for back pain? Now comes evidence from researchers in Denmark and the UK that in some (not all) cases, lower back pain may actually stem from ...

Continue reading on: Big Think  More like this

 
Update
1

6 days ago

Sensex may slip to 19542-19450: Angel Broking

Source: Moneycontrol.com  |   May 13 2013, 11:01pm CDT

According to technical report by Angel Broking, if the Sensex sustains below Monday’s low of 19667 then the possibility of testing the 19542-19450 levels cannot be ruled out. On the upside 19851-19964 levels may act as resistance for the day. Like ...

Continue reading on: Moneycontrol.com  More like this

 
 
  • Visit our Homepage for the Trending TV News.
 
Auto Balla Sexy Balla Sport Balla TV Balla Politics Balla Movie Balla Apple Balla Business Balla Ad Balla Celebrity Balla